10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
GILEAD SCIENCES, INC. | |||
Ticker: GILD Fiscal Year: 2009 | |||
Statement Of Cash Flows Indirect | |||
Period Ending Dec 31, 2009 10-K (Filed: Mar 1, 2010) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
| Operating activities: | |||
| Net income | $ 2,625,592 | 1,970,335 | 1,575,794 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation | 64,560 | 51,722 | 36,888 |
| Amortization | 148,384 | 103,888 | 64,472 |
| Purchased in-process research and development expense | 0 | 10,851 | 0 |
| Stock-based compensation expenses | 180,684 | 153,364 | 184,605 |
| Excess tax benefits from stock-based compensation | (80,186) | (191,939) | (76,276) |
| Tax benefits from employee stock plans | 88,368 | 209,519 | 110,678 |
| Deferred income taxes | (42,013) | (24,969) | 113,384 |
| Other non-cash transactions | 64,456 | (11,257) | (8,082) |
| Changes in operating assets and liabilities: | |||
| Accounts receivable, net | (356,462) | (257,161) | (138,034) |
| Inventories | (75,266) | (330,726) | (34,619) |
| Prepaid expenses and other assets | (65,667) | 9,719 | (252,489) |
| Accounts payable | 203,641 | 312,568 | (77,549) |
| Income taxes payable | 166,334 | (23,887) | 76,986 |
| Accrued liabilities | 109,026 | 136,276 | 80,087 |
| Deferred revenues | 48,603 | 25,081 | 13,237 |
| Net cash provided by operating activities | 3,080,054 | 2,143,384 | 1,669,082 |
| Investing activities: | |||
| Purchases of marketable securities | (2,614,046) | (3,273,112) | (3,502,119) |
| Proceeds from sales of marketable securities | 1,440,509 | 3,026,459 | 2,134,348 |
| Proceeds from maturities of marketable securities | 435,510 | 193,690 | 195,395 |
| Acquisitions, net of cash acquired | (1,247,816) | (10,851) | (46,443) |
| Purchases of non-marketable equity securities | 0 | 0 | (5,000) |
| Capital expenditures and other | (230,057) | (115,005) | (78,648) |
| Net cash used in investing activities | (2,215,900) | (178,819) | (1,302,467) |
| Financing activities: | |||
| Proceeds from issuances of common stock | 222,728 | 246,125 | 243,427 |
| Proceeds from credit facility | 400,000 | 0 | 0 |
| Repayment of credit facility | (400,000) | 0 | 0 |
| Repurchases of common stock | (998,495) | (1,969,582) | (487,543) |
| Extinguishment of long-term debt | (305,455) | 0 | 0 |
| Repayments of long-term debt and other obligations | (5,648) | (4,326) | (99,459) |
| Excess tax benefits from stock-based compensation | 80,186 | 191,939 | 76,276 |
| Distributions (to) from noncontrolling interest | (44,754) | 61,275 | 96,316 |
| Net cash used in financing activities | (1,051,438) | (1,474,569) | (170,983) |
| Effect of exchange rate changes on cash | 940 | 1,220 | (43,553) |
| Net change in cash and cash equivalents | (186,344) | 491,216 | 152,079 |
| Cash and cash equivalents at beginning of period | 1,459,302 | 968,086 | |
| Cash and cash equivalents at end of period | 1,272,958 | 1,459,302 | 968,086 |
| Supplemental disclosure of cash flow information: | |||
| Interest paid | 8,990 | 7,388 | 7,480 |
| Income taxes paid | 746,224 | 495,544 | 565,156 |
| External Links | |
| GILEAD SCIENCES, INC. (GILD) Fiscal Year 2009 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |